Compare PARK & RSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PARK | RSF |
|---|---|---|
| Founded | 1972 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.5M | 63.1M |
| IPO Year | 2025 | N/A |
| Metric | PARK | RSF |
|---|---|---|
| Price | $15.50 | $14.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 57.9K | 11.8K |
| Earning Date | 02-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.61% |
| EPS Growth | ★ 3.18 | N/A |
| EPS | ★ 2.91 | N/A |
| Revenue | ★ $240,209,000.00 | N/A |
| Revenue This Year | $7.62 | N/A |
| Revenue Next Year | $5.75 | N/A |
| P/E Ratio | $5.21 | ★ N/A |
| Revenue Growth | ★ 7.47 | N/A |
| 52 Week Low | $9.53 | $14.81 |
| 52 Week High | $17.84 | $16.23 |
| Indicator | PARK | RSF |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 55.26 |
| Support Level | N/A | $14.31 |
| Resistance Level | N/A | $14.70 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 65.38 |
Park Dental Partners Inc is a dental resource organization (DRO) operating through its subsidiary. It Provides comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to its affiliated general and multi-specialty dental practices throughout Minnesota and Wisconsin. Its network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics, under long-term agreements with initial terms of 30-years, with automatic 5-year renewals.
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.